NEUROMEDIN U-25 (HUMAN)(CAS: 312306-89-1)

NEUROMEDIN U-25 (HUMAN) is a peptide with a molecular weight of approximately 2500 Da. It is soluble in water and is stable under standard laboratory conditions. The compound typically exists as a crystalline form, making it easy to purify. It is reactive towards proteases and should be stored in an appropriate buffer to minimize degradation.

NEUROMEDIN U-25 (HUMAN) is typically synthesized using solid-phase peptide synthesis (SPPS) techniques. The synthesis involves the stepwise addition of amino acids to a solid support, followed by cleavage from the support and purification. Commonly, Boc-protected amino acids are used, and the final peptide is deprotected and cleaved from the resin under strong basic conditions. The yield from such synthesis can range from 50% to 90%.

NEUROMEDIN U-25 (HUMAN) is primarily used in the pharmaceutical and biotechnology industries for its potential as a therapeutic agent. It is also used in research for studying biological functions and signaling pathways. Additionally, it may have applications in the development of biosensors and as a research tool in neuroscience.

When handling NEUROMEDIN U-25 (HUMAN), it is crucial to use appropriate personal protective equipment (PPE) such as gloves, safety glasses, and a lab coat. The compound should be handled in a well-ventilated area or a fume hood to minimize inhalation risks. Spills should be cleaned up carefully using appropriate absorbent materials, and the area should be decontaminated. Always refer to the safety data sheet (SDS) for detailed handling instructions and emergency procedures.